<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ARRY News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=arry</link><description>Latest Financial News for Array BioPharma Inc.</description><language>en-US</language><lastBuildDate>Tue, 18 Jun 2013 22:04:17 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: ARRY News</title><link>http://finance.yahoo.com/q/h?s=arry</link><width>144</width><height>45</height></image><item><title>Nasdaq stocks posting largest percentage decreases</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220405299--finance.html</link><description></description><guid isPermaLink="false">yahoo_finance/810963115</guid><pubDate>Tue, 18 Jun 2013 22:04:17 GMT</pubDate></item><item><title>InPlay: Array BioPharma Announces Positive Interim Results for ARRY-520</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/mp#arry</link><description></description><guid isPermaLink="false">yahoo_finance/3291850071</guid><pubDate>Mon, 17 Jun 2013 12:01:11 GMT</pubDate></item><item><title>Array BioPharma Announces Positive Interim Results From Combination Trial Of ARRY-520 With Kyprolis At The 2013 European Hematology Association Congress</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-announces-positive-interim-120000819.html</link><description>[PR Newswire] - BOULDER, Colo. , June 17, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that interim results from an ongoing ARRY-520 clinical trial in multiple myeloma (MM) were presented at ...</description><guid isPermaLink="false">yahoo_finance/1774039905</guid><pubDate>Mon, 17 Jun 2013 12:00:00 GMT</pubDate></item><item><title>ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130617/arry8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3748663924</guid><pubDate>Mon, 17 Jun 2013 05:02:47 GMT</pubDate></item><item><title>Array BioPharma To Present At The Wells Fargo Securities Research And Economics 2013 Healthcare Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-present-wells-fargo-134300614.html</link><description>[PR Newswire] - BOULDER, Colo., June 13, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Research and ...</description><guid isPermaLink="false">yahoo_finance/4182847056</guid><pubDate>Thu, 13 Jun 2013 13:43:00 GMT</pubDate></item><item><title>Array BioPharma Becomes Oversold (ARRY)</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=12vgtt2gg/*http://www.forbes.com/sites/dividendchannel/2013/06/11/array-biopharma-becomes-oversold-arry/?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/3688016268</guid><pubDate>Tue, 11 Jun 2013 16:07:20 GMT</pubDate></item><item><title>ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130610/arry8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3606053949</guid><pubDate>Mon, 10 Jun 2013 14:17:04 GMT</pubDate></item><item><title>All About ASCO: 2013 Highlights</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12mntuisl/*http://www.fool.com/investing/general/2013/06/08/all-about-asco-2013-highlights.aspx?source=eogyholnk0000001</link><description></description><guid isPermaLink="false">yahoo_finance/4184635766</guid><pubDate>Sat, 08 Jun 2013 16:05:00 GMT</pubDate></item><item><title>Array BioPharma Announces Exercise Of Underwriters&apos; Option To Purchase An Additional $17.25 Million Of 3.00% Convertible Senior Notes</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-announces-exercise-underwriters-120000312.html</link><description>[PR Newswire] - BOULDER, Colo., June 7, 2013 /PRNewswire/ -- Array BioPharma Inc. (NasdaqGM: ARRY) announced today that the underwriters in its previously announced offering of 3.00% Convertible Senior Notes Due 2020 ...</description><guid isPermaLink="false">yahoo_finance/3601039284</guid><pubDate>Fri, 07 Jun 2013 12:00:00 GMT</pubDate></item><item><title>Monday&apos;s Top Biotech Losers Infinity And Synta And Other Top Sells By Fund Managers</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13tv9mbfc/*http://seekingalpha.com/article/1481761-monday-s-top-biotech-losers-infinity-and-synta-and-other-top-sells-by-fund-managers?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1980557880</guid><pubDate>Wed, 05 Jun 2013 11:57:48 GMT</pubDate></item><item><title>Array BioPharma Announces Pricing of Public Offering of $115 Million of Convertible Senior Notes</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-announces-pricing-public-030000973.html</link><description>[PR Newswire] - BOULDER, Colo., June 4, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that it has priced its previously announced offering of convertible senior notes in an underwritten public ...</description><guid isPermaLink="false">yahoo_finance/933049954</guid><pubDate>Wed, 05 Jun 2013 03:00:00 GMT</pubDate></item><item><title>New Date And Time For Array BioPharma Presentation At The Jefferies 2013 Global Healthcare Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/date-time-array-biopharma-presentation-193300843.html</link><description>[PR Newswire] - BOULDER, Colo., June 4, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced a new presentation date and time for its Chief Executive Officer, Ron Squarer, at the Jefferies 2013 Global ...</description><guid isPermaLink="false">yahoo_finance/996878051</guid><pubDate>Tue, 04 Jun 2013 19:33:00 GMT</pubDate></item><item><title>Array BioPharma Announces Proposed Public Offering of Convertible Debt</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-announces-proposed-public-202400731.html</link><description>[PR Newswire] - BOULDER, Colo., June 3, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that it plans to offer, subject to market and other conditions, convertible senior notes due 2020 of approximately ...</description><guid isPermaLink="false">yahoo_finance/2545614041</guid><pubDate>Mon, 03 Jun 2013 20:24:00 GMT</pubDate></item><item><title>Two Array Invented MEK Inhibitors Showcased At ASCO</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/two-array-invented-mek-inhibitors-130000110.html</link><description>[PR Newswire] - BOULDER, Colo., June 3, 2013 /PRNewswire/ -- Two Array BioPharma-invented MEK inhibitors, selumetinib and MEK162, were showcased at the 49th annual meeting of the American Society of Clinical Oncology ...</description><guid isPermaLink="false">yahoo_finance/1745501231</guid><pubDate>Mon, 03 Jun 2013 13:00:00 GMT</pubDate></item><item><title>ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130603/arry8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4127831245</guid><pubDate>Mon, 03 Jun 2013 09:58:51 GMT</pubDate></item><item><title>China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch &amp; Lomb Buy</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=143u1rhkt/*http://seekingalpha.com/article/1474871-china-biotech-in-review-valeant-pharma-gains-sales-foothold-in-china-with-bausch-lomb-buy?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1752878206</guid><pubDate>Sun, 02 Jun 2013 06:55:28 GMT</pubDate></item><item><title>Five Promising Cancer Drug Results</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=12qs5ibgn/*http://www.forbes.com/sites/matthewherper/2013/06/01/five-promising-cancer-drug-results/?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/439582323</guid><pubDate>Sat, 01 Jun 2013 15:01:37 GMT</pubDate></item><item><title>ASCO &apos;13: Array Drug First to be Effective Against Melanoma of the Eye</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13lemn8tp/*http://www.thestreet.com/story/11937824/1/asco-13-array-drug-first-to-be-effective-against-melanoma-of-the-eye.html?puc=yahoo&amp;cm_ven=YAHOO</link><description></description><guid isPermaLink="false">yahoo_finance/3109535382</guid><pubDate>Sat, 01 Jun 2013 11:35:00 GMT</pubDate></item><item><title>Array/ONTY to Co-develop ARRY-380</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-onty-co-develop-arry-193001134.html</link><description></description><guid isPermaLink="false">yahoo_finance/359384403</guid><pubDate>Fri, 31 May 2013 19:30:01 GMT</pubDate></item><item><title>Array BioPharma To Present At The Jefferies 2013 Global Healthcare Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-present-jefferies-2013-004600487.html</link><description>[PR Newswire] - BOULDER, Colo., May 30, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2013 Global Healthcare Conference ...</description><guid isPermaLink="false">yahoo_finance/367639744</guid><pubDate>Fri, 31 May 2013 00:46:00 GMT</pubDate></item></channel></rss>